Sunday, October 11, 2026
ExploreSearch
Via News
MarketIndexes

NYSE Composite Bullish By 3% In The Last 5 Sessions

ViaNews Editorial Team

August 14, 2024

NYSE Composite Bullish By 3% In The Last 5 Sessions

(VIANEWS) - NYSE Composite (NYA) has been up by 3.39% for the last 5 sessions. At 10:14 EST on Wednesday, 14 August, NYSE Composite (NYA) is $18,444.09.

About NYSE Composite's yearly highs and lows, it's 26% up from its 52-week low and 2.11% down from its 52-week high.

News about

  • According to FXStreet on Monday, 12 August, "In summary, the NASDAQ Elliott Wave Analysis on the weekly chart highlights an ongoing upward trend within Orange Wave 5, following the completion of Orange Wave 4. ", "The NASDAQ Elliott Wave Analysis on the weekly chart reveals that the market is currently in a robust upward trend, characterized by an impulsive mode. "

More news about NYSE Composite (NYA).

Categories

MarketIndexes

Tags

NYAIndexWorld IndicesIndicesNYSE CompositePrice UpINDICES Price UpIndex Now
ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic Enterprise Software Consolidates: Big Platforms Push Autonomy While Startups Get Absorbed
Enterprise software is shifting toward autonomous, AI-agent-driven products. SAP (Autonomous Enterprise, Joule), Meta (a new Enterprise Platform led by ex-MongoDB CEO Chirantan Desai) and UiPath (raised guidance) are pushing from the top. Meanwhile AI-security and governance startups are being acquired (Fortinet–Virtue AI, Harvey–Guardrails AI, Tiny–Oso Cloud) and seed-stage agent companies keep raising capital (Dextr, Latitude, Groq). Investors such as Norwest's Sean Jacobsohn see finance and ERP back-office software as the easier area to disrupt. Trust and enforced governance are treated as preconditions for regulated sectors like finance, and AI is judged unreliable for calculations.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,366 source documents archived
Query this data → isubstrate.com